27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- Raymond James upgraded Masimo Corporation (NASDAQ:MASI) from Market Perform To Outperform with a price target of $187 and says that no other company in its coverage offers as many paths to incremental value creation.
- The analyst writes that the stock setup seems attractive despite the uncomfortable headline P/E multiple.
- A vibrant pipeline adds new growth drivers and potential upside to year estimates.
- The analyst sees the 2H23 approval/launch of Stork (baby monitor) as a near-term sentiment driver, with hearables/wearables as a potential long-tailed growth opportunity.
- The IP suit with Apple Inc (NASDAQ:AAPL), as well as the activist involvement, add optionality to the stock.
- Related: Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case.
- The stock has been a modest outperformer YTD (MASI is +500 bp vs. Med Tech/XHE), but the stock was one of the worst Med Tech performers of 2022 (-50%).
- While expecting periodic dislocations along the way, the analyst believes the value creation opportunity is significant.
- Price Action: MASI shares are up 3.62% at $166.72 on the last check Wednesday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!